Honest Company Inc vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Honest Company Inc trades at $4.99 (market cap $533.20M), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.74B). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 3.3× Honest Company Inc's market cap, and Honest Company Inc is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Honest Company Inc for 39 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| HNST | NUVB | |
|---|---|---|
Market Cap | $533.20M | $1.74B |
Volume | 1,990,155 | 9,289,619 |
Sector | Consumer Staples | Health |
52-Week High | $5.95 | $9.54 |
52-Week Low | $2.10 | $3.41 |
Typical Hold Time | 39 Days | 0 Days |
Enterprise Value | $436.81M | $1.33B |
Signals from Pluang's Aura AI — not financial advice
HNST trades at $4.93, down 1.99% on the day, with a bearish technical outlook and mixed fundamentals. The company reported Q2 2026 EPS of $0.04, beating expectations, but maintains negative net income margins. Revenue declined to $371.32M in 2025, though cash flow from operations improved to $15.12M. Analyst sentiment is cautious with a $5.30 consensus target, while institutional interest includes recent investments from BlackRock and Deutsche Bank.
The stock faces headwinds from sustained profitability challenges and competitive pressures, but strategic exits and cost reductions show early turnaround signs. Upside potential exists if margin improvements continue, though investors should weigh execution risks against the current valuation premium (P/E 48.83).
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →